# PKSHA Technology

PKSHA Technology is an Asset Manager based in Tokyo, Japan.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Tokyo, Japan
- **Region:** Asia
- **Address:** Tokyo, Japan
- **Assets under management:** Undisclosed
- **Website:** www.pkshatech.com

## Regulatory record

- **Reports private funds:** No

## About

PKSHA Technology is a Tokyo-based company founded in 2012. It develops software and hardware using deep learning in the AI sector. PKSHA Technology conducts research and development of AI solutions that utilize natural language processing, image recognition, and machine learning/deep learning techniques, collaborating with partner companies and universities.

## Sectors

- AI/ML
- Enterprise Software
- Digital Health
- FinTech

## People

- 上野山 勝也 — 代表取締役社長

## Questions

### How does PKSHA Technology source proprietary deal flow?

PKSHA Technology generates deal flow through its client engagements and joint development projects. For example, it co-developed an AI screening model with クレディセゾン and a RoboPad AI Agent Studio with ＦＣＥ, both announced in April 2026 (per the firm). These relationships often stem from existing customer needs.

### What investment stages does PKSHA Technology typically target?

PKSHA Technology does not function as an allocator or fund investor. It is a technology company that develops custom and packaged AI solutions for enterprise clients across various stages of AI adoption, from initial deployment to scaling.

### Which sectors does PKSHA Technology explicitly focus on?

Based on its product announcements and website, PKSHA Technology focuses on enterprise AI across sectors including financial services (joint development with クレディセゾン), business process automation (with ＦＣＥ), and broader natural language, image recognition, and deep learning applications. It does not publicly exclude any sectors.

### What is PKSHA Technology's known posture on co-investments or partnerships?

PKSHA Technology actively engages in joint development partnerships with other companies, as demonstrated by the クレディセゾン and ＦＣＥ collaborations announced in April 2026 (per the firm). These are product co-development agreements, not capital co-investments.

## Related profiles

- [H Robotics Inc.](https://altss.com/profile/h-robotics-inc)
- [Medical Genetics Center](https://altss.com/profile/medical-genetics-center)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/pksha-technology

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology